ERS
With multiple national and international meetings taking place throughout the year, deciding which conferences to attend isn't always straightforward. While scientific programs are an important consideration, opportunities for networking, collaboration, career development and practical learning can be just as valuable. To help identify the meetings making the biggest impact across respiratory and pulmonary medicine and related specialties, we asked members of the touchRESPIRATORY community their non-negotiable conferences and what makes them worth attending.
Your clinical career is shaped not only by what you know, but by who helps you navigate what comes next. Join us for the final episode in our mini-series exploring non-clinical skills that can help you thrive in your clinical career. Today we explore how to develop the right team around you to support your work, and what building that bench can mean for your career, and the life you build alongside it.
We often focus on clinical excellence, but spend less time developing broader skills that could help us better lead with purpose and build more fulfilling, impactful careers. In this episode, part of a mini-series in partnership with LEADderm, Dr Jennifer Soung and Denise Mann explore how clinicians can engage with the media to educate, empower and extend their impact beyond the clinic.
Sleep Awareness Month for Europe is a March-long initiative led by the European Sleep Research Society to highlight the essential role of sleep in overall health and well-being. Aligned with the global “Sleep Well, Live Better” theme of World Sleep Day, the campaign encourages participating countries to promote evidence-based sleep education, with this year’s focus on helping children and adolescents build healthy routines. In this interview, Dr Daniela Ferreira discusses the campaign’s objectives, key target groups, and how public awareness connects with clinical practice—offering a concise overview of why sleep matters across the lifespan.
The PVRI 2026 Congress in Dublin marked not only the return of a global gathering of pulmonary vascular specialists, but also a significant milestone—the 20th anniversary of the Pulmonary Vascular Research Institute (PVRI). Under the theme “Celebrating 20 Years of Progress & Innovation,” the meeting offered an opportunity to reflect on 2 decades of scientific advancements, while looking ahead to the future of pulmonary vascular research and care.
We are delighted to welcome Dr Alexander G Mathioudakis, Senior Lecturer in Respiratory Medicine at the University of Manchester and Honorary Consultant Respiratory Physician at Manchester University NHS Foundation Trust, to the Editorial Board of touchREVIEWS in Respiratory & Pulmonary ...
As 2025 draws to a close, we’re celebrating another remarkable year of growth, collaboration and innovation at touchRESPIRATORY. From thought-provoking expert interviews and peer-reviewed research to dynamic conference coverage and an expanding portfolio of medical education, this year has been defined by meaningful conversations and impactful learning. We’ve had the privilege of engaging with leading clinicians, researchers and partner societies across the globe - bringing together diverse voices to support the respiratory community with timely, accessible and authoritative content. As we reflect on the past 12 months, we’re proud to highlight the moments, milestones and stories that shaped our year.
The ERS Congress 2025 in Amsterdam showcased the latest advances in respiratory medicine, featuring cutting-edge research, interactive workshops, and sessions across 14 specialist assemblies. Highlights included live endoscopy demonstrations, updates on lung cancer projects, and innovative programmes for early career professionals. This year’s congress underscored global collaboration and innovation in respiratory health. touchRESPIRATORY were delighted to speak with leading experts at ERS 2025, sharing insights on some of the congress’s key presentations and breakthroughs in respiratory medicine.
Extreme weather and air pollution can pose serious risks for people living with asthma and COPD. In this interview, Dr Tugce Karamustafalioglu discusses her award-winning study on how heatwaves and poor air quality worsen symptoms, reduce quality of life, and increase exacerbations, while offering practical advice for protecting vulnerable patients.
The phase 2 TIDE-Asthma (NCT05421598) study is investigating amlitelimab, an OX40L inhibitor, as an add-on therapy for moderate-to-severe asthma. In this Q&A, Dr Praveen Akuthota discusses the drug’s mechanism of action, study aims and design, key clinical endpoints, the findings shared at the ERS International Congress 2025, and the potential impact on future asthma treatment.
RT234 is a novel investigational therapy combining inhaled dry powder vardenafil with a proprietary oscillating inhaler, designed for rapid, on-demand relief of breathlessness in patients with pulmonary arterial hypertension (PAH). In a phase 2b CPET study, RT234 demonstrated dose-dependent improvements in peak VO₂ and dyspnea.
As part of our ATS 2025 coverage, Dr Raymond Benza discusses these findings, current treatment limitations, and the next steps toward a phase III clinical trial.
Ventilator-associated pneumonia (VAP) poses a serious threat in ICUs, often driven by biofilms on endotracheal tubes that resist antibiotics.
In this Q&A, Professor Frank MP van Haren discusses a study showing that nebulized BromAc® effectively disrupts these biofilms and enhances antibiotic action, offering a promising strategy against persistent infections like Pseudomonas aeruginosa-related VAP.
In this interview, Dr Mural Quadros (St John’s University, New York, USA) discusses her presentation from the ATS International Conference in San Francisco, on a preclinical study evaluating inhaled osimertinib for malignant pleural mesothelioma (MPM). The research highlights the use of PLGA nanoparticles to deliver the drug directly to the lungs, offering a non-invasive, targeted alternative to current treatment options.
Back in February 2025, the 7th Forum on Respiratory Tract Infections (RTI) took place at the iconic Glasgow Science Centre - a fitting venue for a scientific conference built on innovation, collaboration and ground-breaking research. Each year RTI continues to grow ...
As part of our Future Leaders series, we speak with Dr Helen Gavillet, a post-doctoral researcher at Northumbria University (UK) and Rising Star at RTI 2025. Dr Gavillet's research focuses on the lung microbiome in cystic fibrosis, particularly bacterial and fungal dynamics. Her research also examines the impact of CFTR modulators like elexacaftor/tezacaftor/ivacaftor on respiratory microbiota.
#AAAAI2025: Must-know Updates in Chronic Rhinosinusitis - Key Data from the AAAAI/WAO Joint Congress
The 2025 AAAAI and WAO joint congress highlighted advances in chronic rhinosinusitis (CRS) treatment. Notable studies presented positive results for novel biologic therapies, including tezepelumab, depemokimab and mepolizumab for chronic rhinosinusitis with nasal polyps (CRSwNP), and dupilumab for chronic rhinosinusitis without nasal polyps (CRSsNP). These findings highlight significant advancements in symptom management, offering hope for improved patient outcomes and reduced treatment burdens.
Artificial intelligence is no longer a futuristic concept in respiratory care — it's already here, reshaping how we diagnose and manage asthma. In this insightful interview, Dr Alan Kaplan shares how AI is helping bridge long-standing gaps in asthma diagnosis, adherence, and disease control. From apps that can tell the difference between asthma and COPD, to smart inhalers that track medication use and predict exacerbations, Dr Kaplan explores the real-world potential of AI — and the challenges that come with it. He also weighs in on whether AI scribe software can enhance the patient–physician relationship, and what excites him most about the road ahead.
The unmet need for effective treatments for childhood interstitial lung diseases (ILDs) is significant, with no drugs currently approved for this vulnerable population—unlike in adult patients.
touchRESPIRATORY
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
